Share This Article:

A Clinical Research about the Intermittent Medication Treatment on the Female Urogenital Tract Mycoplasma Infection

Abstract Full-Text HTML Download Download as PDF (Size:2484KB) PP. 800-804
DOI: 10.4236/ojog.2014.413110    1,717 Downloads   2,013 Views  

ABSTRACT

Object: To explore a better treatment on the female urogenital tract mycoplasma infection so as to ensure the health of female reproduction. Method: 115 female patients with urogenital tract mycoplasma infection are selected, including 63 patients acted as a group for intermittent medication treatment; that is to say, the ones that are confirmed to be sensitive drugs to those 63 patients are chosen, and let them take this medication for 15 days and stop taking it for 7 days and after that continue to take it for 10 days. The other 52 patients in the other group which acts as a contrast to the former group are cured with a course of conventional treatment for 15 - 21 days. Results: As to those 115 female patients with urogenital tract mycoplasma infection, 43 patients get relapsed, and 27 patients of them are in the contrast group and 16 patients are in the treatment group. There is obvious difference on the contrast of relapse rate between the treatment group and contrast group, and they are P < 0.01. But as to the sensitive testing results of 10 common antibiotic medicines, there are cases of illness of relapse in those 2 groups, and the rate of drug sensitivity in the treatment group is higher than that of the contrast group. Between treatment group and contrast group, there is obvious difference in the sensitivity of the drugs, P < 0.05 average. Conclusion: When the female patients with urogenital tract mycoplasma infection are cured with a traditional treatment, because of the side effects of drugs, they are not likely to take medicines that are required to making the cure rate become lower and the relapse rate become higher. But intermittent medication is designed with the half-life period of medicine, which makes the medicine can be digested and absorbed easily, and the cure rate is high and the relapse rate is low. With this research we found a more effective method of the treatment on the female urogenital tract mycoplasma infection and showed the clinical significance in intermittent medication.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Su, G. , Luo, X. , Liang, R. and Pan, L. (2014) A Clinical Research about the Intermittent Medication Treatment on the Female Urogenital Tract Mycoplasma Infection. Open Journal of Obstetrics and Gynecology, 4, 800-804. doi: 10.4236/ojog.2014.413110.

References

[1] Vandepitte, J., Bukenya, J., Hughes, P., et al. (2012) Clinical Characteristics Associated with Mycoplasma Genitalium Infection among Women at High Risk of HIV and Other STI in Uganda. Sexually Transmitted Diseases, 39, 487-491. http://dx.doi.org/10.1097/OLQ.0b013e31824b1cf3
[2] Vandepitte, J., Weiss, H.A., Kyakuwa, N., et al. (2013) Natural History of Mycoplasma Genitalium Infection in a Cohort of Female Sex Workers in Kampala, Uganda. Sexually Transmitted Diseases, 40, 422-427. http://dx.doi.org/10.1097/OLQ.0b013e31828bfccf
[3] Vandepitte, J., Weiss, H.A. and Bukenya, J. (2013) Alcohol Use, Mycoplasma Genitalium, and Other STIs Associated with HIV Incidence among Women at High Risk in Kampala, Uganda. Journal of Acquired Immune Deficiency Syndromes, 62, 119-126.
http://dx.doi.org/10.1097/QAI.0b013e3182777167
[4] McGowin, C.L., Annan, R.S., Quayle, A.J., et al. (2012) Persistent Mycoplasma Genitalium Infection of Human Endocervical Epithelial Cells Elicits Chronic Inflammatory Cytokine Secretion. Infection and Immunity, 80, 3842-3849. http://dx.doi.org/10.1128/IAI.00819-12
[5] Vandepitte, J., Muller, E., Bukenya, J., et al. (2012) Prevalence and Correlates of Mycoplasma Genitalium Infection among Female Sex Workers in Kampala, Uganda. Journal of Infectious Diseases, 205, 289-296. http://dx.doi.org/10.1093/infdis/jir733

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.